ROTATING HEMOSTATIC VALVE— 510(k) K873971

Name: FDA 510(k) clearance K873971
Creator: U.S. Food and Drug Administration
Published: 1988-01-19

Substantially Equivalent

Target Therapeutics

FDA 510(k) clearance K873971 for ROTATING HEMOSTATIC VALVE, Substantially Equivalent on 1988-01-19. Applicant: Target Therapeutics. Device class: 2.

Clearance details

Applicant: Target Therapeutics
Product code: Code DTL
Device class: Class 2
Regulation: 21 CFR 870.4290
Advisory panel: Cardiovascular
Date received: 1987-09-29
Decision date: 1988-01-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Los Angeles, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DTL

view all

K152528 — Attachable Cath Lab Hemostasis Valve2015-12-02
K143429 — Passage Hemostasis Valve2014-12-22
K140475 — ROTATING ADAPTERS2014-04-16
K131124 — COLIGN2013-08-28
K123448 — AFFINITY FLEXIBLE LUER LOCK ADAPTER WITH BALANCE BIOSURFACE, AFFINITY FLEXIBLE LUER LOCK ADAPTER WITH CARMEDA BIOACTIVE2012-12-13

More clearances from Target Therapeutics

view all

K964488 — DETACHABLE SILICONE BALLOON (DSB)1998-04-21
K965071 — DETACHABLE SLICONE BALLOON (DSB)1998-04-21
K964210 — RETRIEVER II1997-10-31
K971395 — GUGLIELMI DETACHABLE COIL (GDC), FIBERED PLATINUM COIL, .035 TYPE, BERENSTEIN LIQUID COIL, FIBERED PLATINUM COILS, ACCE1997-07-14
K965189 — SPINNAKER1997-03-24

Adverse events under product code DTL

product code DTL

Malfunction: 770
Total: 770

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.